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Summary Expression of tissue factor (TF), a cellular initiator of the extrinsic coagulation cascade, is a feature of many malignant tumours
and is intimately involved in the process of metastasis. SW-480 human colon adenocarcinoma cells responded to thrombin (1 U mM') or
phorbol 12-myristate 13-acetate (PMA, 0.1 rM) with a 6.0-fold and a 7.7-fold increase in their procoagulant activity (PCA), respectively, after
4-6 h incubation in serum-free medium. The thrombin-enhanced PCA was significantly inhibited by complexing of thrombin with hirudin, or by
senne protease inhibition with 3,4-dichloroisocoumarin. Both effects of thrombin and PMA on PCA in SW-480 cells were blocked by
pretreatment of cells with cycloheximide or actinomycin D, indicating that the response required de novo protein and RNA synthesis. The
thrombin-enhanced PCA depended on the activation of protein kinase C (PKC) as it was diminished by staurosponne and calphostin C.
Moreover, stimulation of SW-480 cells by thrombin or PMA led to a significant increase in TF mRNA within 3 h as measured by the reverse-
transcription PCR method, which was also dependent on the activation of PKC. The unattered decay rate of thrombin-enhanced TF mRNA,
evaluated after the addition of staurosporine, suggested that its inhibitory effect occurred at a transcription level. Our data suggest that
thrombin enhances TF gene expression and protein synthesis in tumour cells in vitro via PKC activation. The induction of TF expression in
tumour cells by thrombin indicates that tumour-associated PCA might have a positive-feedback effect on in vivo local propagation ofthrombus
by thrombin formation.
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Tissue factor (TF). a 47-kDa integral membrane glycoprotein. is
an essential co-factor for factor VIWINHa. which triggers the cell-
surface assemblv of coagulation protease cascade. finally leading
to formation and deposition of fibnrn (Altieri and Edgington.
1988). The constitutively expressed TF is preferentially detectable
in the extravascular cells ofmany tissues (Drake et al. 1989: Fleck
et al. 1990) such as epidermis. cerebral cortex. kidney glomeruli.
mucosal epithehial lavers and adventitia of -essels. Within the
xasculature. endothelium lacking TF under physiological condi-
tions can be stimulated bv endotoxins. thrombin or cytokines to
start de novo TF synthesis (Brox et al. 1984: Edgington et al. 1991:
Tijburg et al. 1991 ). Similar results have been found in monocytes.
in which TF synthesis is stimulated by a variety of inflammatorx
mediators and antigen-specific cellular immune responses
(Edgington et al. 1991 ). Howe%-er. little is known about the regula-
tory mechanisms of constitutive TF expression detected in the
cells of certain malignant tumours (Callander et al. 1992: Chiang
etal. 1994. 1995).
It has been known that most cancer patients manifest signs of
hypercoagulability and some develop thromboembolic disease
(Bick. 1992: Rickles et al. 1992). There is evidence that systemic
or local actix ation of blood coagulation promotes metastasis.
whereas inhibition of the blood-clotting cascade favours the host
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and diminishes metastatic spread (Honn and Sloane. 1984).
Therefore. it has been suggested that an efficient metastasis of
tumour cells is possibly dependent on the plasma coagulation
cascades. Tumour-associated procoagulant activity (PCA) is
thought to lead to local thrombin generation and peritumour fibrin
formation in the presence of an intact local coagulation pathway.
which has been considered a potentially important characteristic in
the malignant state (Zacharski et al. 1990). Although an alternative
pathway exists to activate coagulation. including a tumour cell
proteinase-designed cancer procoagulant (Gordon et al. 1975). the
in vixo activation of this proteinase system predominantly
proceeds xia the TF pathway (Daxie et al. 1991) arising from
constitutive TF expression in a varietv of tumour cell lines.
Indeed. the role ofTF in promoting metastasis has been shown in a
melanoma metastasis model (Fidler. 1986: Mueller et al. 1992) in
which melanoma cell lines expressing high levels of TF exhibited
metastasis stronglv. whereas the metastatic potential of the cell
lines could be inhibited by treatment with an anti-TF MAb that
blocked its PCA. These results suggested that certain compo-
nent(s) of the coagulation cascade might mediate the metastasis
effect of TF expression on tumour cells. Thrombin. a pluripotent
bioregulatorv senine proteinase. has been reported to enhance the
metastatic phenotype of mammary tumour cells by inducingy their
proliferative response (Medrano et al. 1987) and found to be a
potent mitogen for tumour cells (Bruhn and Zurborn 1983).
Adhesion oftumour cells to platelets (Nierodzik et al. 1991. 1992).
endothelium (Wojtukiewicz et al. 1993) and the subendothelial
matrix (Klepfish et al. 1993) has also been reported to be
stimulated by thrombin. Furthermore. it has been reported that
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thrombin-treated tumour cells markedly enhanced pulmonary
metastasis (Nierodzik et al. 1991. 1992). Our previous study
showed that thrombin enhanced the adhesive and migratory
activities of SW480 cells via up-regulated03 integrin expression
(Chiang et al, 1996). In addition, thrombin was shown to mediate
tumour cell-induced platelet aggregation (TCIPA) owing to TF
activity expression on SW480 cells (Chiang et al, 1994), which
might be important for successful metastasis to occur (Cavanaugh
et al, 1988).
The aim of our present study is to explore the possible regula-
tion of TF expression in SW480 human adenocarcinoma cells.
Thrombin was found to induce TT mRNA and protein synthesis in
SW480 cells rapidly and markedly, which is dependent on activa-
tion ofprotein kinase C (PKC). The induction ofTF expression in
tumour cells by thrombin suggests that tumour-associated PCA
might have apositive-feedback effect on in vivo local propagation
ofthrombus by thrombin formation.
MATERIALS AND METHODS
Materials
SW480 human colon adenocarcinoma cells were provided by the
Department of Bacteriology, College of Medicine, National
Taiwan University. Human thrombin (3000 NIH units mg-'),
hinrdin (grade IV from leeches), 3,4-dichloroisocoumarin (3,4-
DCI), cycloheximide, actinomycin D and fibronectin (from bovine
plasma), and phospholipase C (Baccillus cereus) were obtained
from Sigma, St Louis, MO, USA. Thrombin-hirudin or
thrombin-serine protease inhibitor complex was formed by incu-
bation for 30 min at 37°C of equimolar concentrations of human
thrombin with either inhibitor (hirudin, 5 U ml-'; 3,4-DCI,
0.1 mM). The tdrombin-hirudin complex exhibited no fibrinogen
clotting activity. Staurosporine was obtained from Biomol
Research Laboratories, PA, USA. Calphostin C (isolated from
Cladosporiwn cladosporioides) was from Research Biochemicals
Intemational, MA, USA. Goat anti-mouse IgG-FITC was from
Boehringer, Mannbeim, Germany. Monoclonal antibody (MAb)
A135 raised against human TF was obtained from Enzyme
Research Labs.
Cell culture
SW-480 human colon adenocarcinoma cells were cultured in a
humidified atmosphere of 5% carbon dioxide and 95% air in a
mixture ofDMEM tissue culture medium supplemented with 10%
heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, peni-
cillin (100 U ml-') and streptomycin (100 mg ml-'). Confluent
monolayers were passaged from culture flasks with brieftratment
of0.1% trypsin-1 mm EDTA.
Treatme of SW-480 cells
For stimulation, cells were harvested from confluent monolayer
cultures after detachment by trypsin-EDTA and seeded in 25-cm'
culture flasks (Costar, MA, USA.) with a complete medium at a
concentration of 1 x 101 cells. After 3 days, cell monolayers were
washed three times with PBS and thecell culture was continuedby
incubation with serum-free DMEM containing various concentra-
tions of thrombin, thrombin-hirudin or thrombin-senine
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Fijure 1 Bar graph of tie course of thrombi on procoagLant TFactivity.
SW-480 cels were inKAated with either senxr-free DMEM ortogether with
thrombin (1 U mn[l) for48 h at 370C. Cellmfnayers were harvested at the
time idcated, and thendesnqped andassayed for PCA, as descrRbed in
Materials and methods. Data of thrombinbeatment are presented as mean
± s.e.m. (n = 3).E,Thrombti-enharced PCA; U, constitutive PCA
tumour cells were harvested mechanically at the desired culture
intervals with a cell scraper (Costar), washed three times with
phosphate-buffered saline (PBS) and adjusted to 5 x 104cells ml-.
Viability oftumourcells was 90-95% as examined by Trypanblue
exclusion. The cell suspension (1 ml) was pelleted by centifuga-
tion and the supematant was decanted; the pellets were then frozen
at-20°C for ftuther experiment.
Measurement of procoagulant acivity
The procoagulant activity (PCA) of cell preparations was
measured by plasma recalcification time (Chiang et al, 1994).
After thawing, the cell pellets were lysed with 30 l of 16 mM
octyl-o-D-glycopyranoside at 37°C for 10 min and diluted in 70 tl
of25 mM Hepes-saline (flossel et al, 1992). Platelet-poor plasma
was prepared from whole blood collected from healthy human
volunteers and mixed with 3.8% (w/v) sodium citrate (9:1, v/v). In
the coagulation assay, 100ILI of normal citrated plasma was incu-
bated with 100 jlI ofthe cell lysate for 2 min at 370C. Thereafter,
100 1 ofprewarmed 25 mm calcium chloride was added, and the
plasma clotting time was determined by a fibrometer (Coag-a-
mate, Organon Teknika, NC, USA). The time recorded was
converted to milliunits (mU) per 5 x 104 cells ofPCA by reference
to a standard curve constructed with serial dilutions ofa commer-
cial thromboplastin (Simplastin, Organon Teknika, USA). The
amount of thromboplastin required to produce a clotting time of
17 s was arbitarily assigned as one PCA unit Todetermine the role
of the TF-factor ViN/Vla pathway in the PCA, normal human
plasma was replaced in some experiments by afactorVII-deficient
plasma. In other control experiments, cells were incubated with
phospholipase C (1 U ml') at 370C for 15 min before the clotting
assay.
Flow cytometric analysis
Flow cytometric studies were performed to quantify surface
expression ofTF antigen (Chiang et al, 1996). SW480 cells were
stimulated with thrombin (1 U ml-l) for 4 h at 370C, detached
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Figure 2 Effect of various concentrations of thrombi
procoagulant activty. Thrombin and PMA at the final
were added to SW-480 cells in serum-free DMEM for
monolayers were then disrupted and assayed for PC)
Materials and methods. Data are presented as mean
(using 0.5 m-LM EDTA). washed and then sus
PBS containing cells per sample. Followi
were fixed with 2.7% paraformaldehyde for I
normal goat serum ( 1:2) for 25 mmn and label
TF MAb (A135. 20 jg ml-' ) for h. After wa
relabelled with goat anti-mouse IgG-FITC.
detected and digitized in logarithmic confi
10 000 cells were counted per experimental
analysed by using a FACScan (Becton Dicd
fluorescence intensity was obtained with cell
primary antibody was replaced with non-imnr
ments were repeated at least four times.
RNA isolation, reverse transcription ar
mRNA
For total RNA preparation. confluent SW48
25-cm' flasks were incubated in serum-free
Figure 3 Effect of hirudin as well as inhibitors of serine proteinase, protein
synthesis and RNA synthesis on thrombin-enhanced TF actvity of SW-480
cells. SW-480 cells were stimulated with optimal dose of thrombin (1 U mt-),
thrormbin-hirudin or thrornbin-3,4-DCI complex (each complex contained
1 U mt- thrombin) for 4 h at 37-C. and then assayed for PCA. In other
experiments cells were incubated with vanous concentrations of
cycloheximide or actinomycin D for 20 min at room temperature before the
addition of thrombin (1 U ml-) for 4 h at 37-C. Data are presented as
mean ± s.e.m. (n = 4)
time intervals with thrombin (1 U ml-') or PMA (0.1 iLm). RNA
was extracted by using the Trizol reagent (Gibco BRL. NY. USA):
0.2 ml of chloroform and 0.5 ml of isopropyl alcohol per I ml of
Trizol reagent were added for phase separation and RNA precipi-
tation respectively, and centrifuged at 12 000 g for 10 min at 4°C.
i________ The RNA pellet was extracted by ethanol. dried, dissolved in 25 tl
-5 -4 of water and the concentration of RNA determined by absorbance
at 260 nm. Purified RNA samples were stored at-20°C.
in (A) and PMA (B) on An appropriate amount of RNA (2-3 gg) was mixed with
concentratons shown 2.5 Im ohigo(dT) primer. hexamer (0.9 jg jF'). heated to 70°C
r4 h at 37^C. Cell and then quickly chilled on ice. Eac i of the above RNA mixtures
A,. as described in
+ se.m. (n - 4) Was for reverse transcription by incubating the mixture at 42 C for
1 h with 200 units of reverse transcriptase (MMLV Superscnrpt II
system: BRL. Bethesda. MD. USA) in a reaction buffer containing
50 m-Ns Tris-HCl (pH 8.3). 75 nmt- potassium chloride. 3 m-s
;pended in 500 gl of magnesium chloride. 10 m-s DTT. 500 -ist of each of the four
ng washing. the cells dNTPs and 40 U of rRNasin (Promega). After synthesis of the
10 min. blocked with first-strain cDNA. aliquots of the RT mixtures were subjected to
[led with human anti- regular PCR (35 rounds of 94CC for min. 55°C for 2 min and
ashing. the cells were 72'C for 2 min) using appropriate pnmer pairs. TF186 and
FITC signals were TFD. The sequences for primers are as follows: TF186 5'
gauration. A total of GGAGAAAACTACTGT1TCAGTGTTCAAGCAGT-GATT 3'.
group and data were corresponding to nucleotides 739-774: and TFD. 5' AATATAG-
kinson). The control CAT-FIGCAGTAGCTCCAACAGTGCTTCC 3'. corresponding
suspension in which to nucleotides 1023-989. The sequences for intemal control. GS-
nune IgG. All experi- like primers. are: Gpa20. 5' GTATGGAACCTGGCTAACTG 3'.
corresponding to nucleotides 620-640: andGfc20. 5' TAGGGCT-
GAAGCACAGGGCG 3'. corresponding to nucleotides 825-806.
nd PCR for TF The amplified samples electrophoresed 2%7 agarose gel.
followed by staining with ethidium bromide. and photographed
with Polaroid 667 negative film. RNA quantification was achieved
;0 cell monolayers in by scanning analysis of the bands using UVP Image Store 2000
DMEM for various (CA. USA) and the NIH IMAGE program.





















+1 U itt mfl in







Figire 4 Effect of staurospoin and capht C on thrombin-enhanced TF
acviy. SW-480 cels were icubated with vanous concentrabons of
staurosporine and caphstin C for 20 rrni at room temperature, then
stinulated with thromnbin (1 U m[') for 4 h at37TC. Data are presented as
mean ± s.e.m. (n=4)
Fpre 5 Effect ofthrofbin and PMA on TF mRNA lvels in SW-480 cels
as revealed by RT-PCR analysis Total celar RNA (2-3gg) was reverse
rancribe and then amplified usng TF- and G pactinecfifc prmers. The
molecular size was determined using Haell DNA molecularmarker. PCR
products of TF and Gfl-actin mRNA were from SW-480 cels cultured for 1, 3,
5 and 7 h in sern-free DMEM alone (anes 1-4 respely), in the
presence of 1 U mf'thronbin for 1, 3, 5 and 7 h (lanes 5-8 respectively), or
0.1 pw PMA for 1, 3, 5 and 7 h (lanes 9-12 respectively).
Transcript stability analysis
The effect of staurosporine on TF mRNA stability was examined
by inhibiting mRNA transcription with actinomycin D. After incu-
bating the cells with thrombin for 2 h. actinomycin D (5 gM) was
added with or without staurosporine (1 gM) and the disappearance
of TF mRNA was analysed by RT-PCR. Values were calculated
relative to the GJ-like control.
RESULTS
Constittive TF expression on SW-480 cells
In the presence of serum-free DMEM without the addition of
thrombin. SW-480 cells harvested from subconfluent monolayer
cultures at various time periods showed neither the enhanced




Thrornbin alone 1787 100
+ staurospofxne 025 gm 983 55
+ staurosporine 0.5g 822 46
+ staurosponne 1 a 393 22
Thrormbin alone 1911 100
+ calphostin C 1.25pm 841 44
+ca2*ostinC2.5gm 382 20
+ calphotinC 5 m 344 18
aSW-480 cells were incubated in the presence ofthrombin (1 U m[1) with or
wthout PKC inhibtors at the in&cated concentrations for 4 h, as descrbed in
Materials and methods. RT4PCRs were prepared with total ceUlular RNA
(2-3±g) and amplfied simultneously orconsecuvely with prners for TF
and G-ike. bAfblrhty urnts. Values wee corected relative to the Gp-like
control. cPercentage of values obtined wihout inhibitor.
constitutive PCA measured by clotting assay (Figure 1) nor the
molecularTFexpression assayed by flow cytometric analysis (data
not shown). No PCA was generated when factor VIl-deficient
plasma instead ofnormal plasma was used in the clotting assay.
Enha e nt of PCA by thrombin and phorbol ester on
SW-480 cells
To study the time course of thrombin-stimulated TF expression.
SW-480cells were cultured with thrombin (1 Uml') over aperiod
of0-48 h, then PCA ofthese treated cells was analysed. Figure I
shows that a significant increment ofPCA was observed after 2-h-
incubation, reaching the maximum at4-6 h. gradually declining to
the basal value within 48 h. During a 4-h incubation, stimulation
ofSW-480 cells with various concentrations ofthrombin exhibited
a bell-shaped dose-response curve in enhancing PCA with a peak
at 1 U ml' (Figure 2A). The maximal effect was approximately
sixfold. After the treatment of 1 U ml thrombin for 4 h at 370C,
an increased expression of TF antigen within the cell population
was found by flow cytometric analysis (data not shown).
It has been reported that the activation of protein kinase C
(PKC) is involved in tumour metastasis and induction of TF
expression in monocytes (Temisien et al, 1993) and epithelial cells
(Terry et al, 1996). Therefore we examined the effect of phorbol
12-myristate 13-acetate (PMA), a phorbol ester directly stimu-
lating PKC, on SW480 TF expression. As shown in Figure 2B.
PMA exhibited a bell-shaped dose-response curve in increasing
PCA with a maximal 7.7-fold effect at 0.1 g. On the other hand,
neither thrombin- norPMA-stimulated SW-480cells were capable
ofinducing PCA in factor VII-deficient plasma, and the enhanced
PCA was reconfumed as increased expression ofTFby the obser-
vation that the enhanced PCA was lost in the presence ofphospho-
lipaseC(l Uml-').
Effects of thrombin inhibitors and metabolic inhibitors
on thrombin-enhanced PCA
Figure 3 shows results ofvarious inhibitors on thrombin-enhanced
TF activity. When thrombin was coupled with hirudin. a specific
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Figure 6 Effect of staurosponne on the stability of thrombin-enhanced TF
mRNA. SW-480 cells were incubated with thrombin (1 U mVt) for 2 h to
enhance TF mRNA Actinomycin D (5 gM) was then added to all samples and
further incubation was performed in the presence or in the absence of
staurosporine (1 jiM). Total mRNA was extracted at the various time intervals
indicated, and TF mRNA was analysed by RT-PCR. The values shown
represent the percentage of maximal TF mRNA obtained just after the
addition of actinomycin D. Data are presented as average value (n = 2)
- Actinomycin D: 7. actnomycin D + staurosporine
thrombin inhibitor. a profound inhibition was obtained when
compared with thrombin alone. This sugaests that an intact
thrombin molecule is apparently required for enhancing TF
activitv of SW480 cells. A similar effect was found by' pretreat-
ment of thrombin with 3A-DCI. an irreversible senine protease
inhibitor. indicating that the catalytic site of serine residue is
required for the enhancing effect ofthrombin. In addition. preincu-
bation of SW480 cells with either actinomycin D or cyclohex-
imide abolished thrombin- or PMA (data not shown--enhanced
PCA. further suggesting that thrombin-enhanced TF activitx
requires mRNA and de novo protein synthesis.
Effects of PKC inhibitors on thrombin-enhanced PCA
The effects of PKC inhibitors were used to examine whether PKC
is implicated in thrombin-enhanced TF activity. As shown in
Figure 4. pretreatment of SW-480 cells with either staurosporine
(0.04-1 JIm). a potent but relatively less selectisve PKC inhibitor. or
calphostin C (0.2-5 Jm). a selective PKC inhibitor. blocked
thrombin-enhanced PCA in a dose-dependent manner. Maximal
inhibition was obsersed to a level of 50-75%7 of control (i.e.
unstimulated) PCA. suggesting that PKC actix-ation is a kev event
in thrombin effect.
Effect of thrombin and PMA on TF mRNA levels
Induction of TF activits could be due to an increase in TF gene
expression or an increase in the rate of initiation ofcoagulation by
the existing TF protein. Therefore. we determined whether
changes in TF mRNA levels could account for the observed induc-
tion of TF activity. TF mRNA was quantified using the reverse
transcription-PCR method. The products of the reverse transcrip-
tion-PCR were analysed on a 2c% agarose gel and stained with
ethidium bromide. When 2-3 go of total RNA of untreated SW-
480 cells were analy sed. TFmRKNA was constutivelv detectable as
a single band hasVing an approximate size of 0.28 kb. corre-
sponding to the size (285 bp) predicted from the published
sequence (Figure 5). The identity was further established by the
cleavage of the 280 bp band by EcoRI into approximately 180-
and 100-bp fragments. Whereas the contents of G,B-actin mRNA
remained unchanged. TF mRNA levels in the control (unstimu-
lated) cells decreased in a time-dependent manner after replace-
ment of serum-free medium. However. following stimulation with
thrombin (1 U ml-') or PMA (0.1 tm). TF mRNA increased
greatly at 3 h incubation and decreased at 5-7 h (Figure 5).
Quantification by densitometry of the amplified TF species and
companson with the G$-actin species demonstrated that TF
mRINA was increased 1.9- and 2.1-fold by thrombin and PMA
respectively. at 3 h incubation.
Effect of thrombin inhibitors on thrombin-enhanced TF
mRNA levels
We compared TF mRNA levels in SW480 cells stimulated with
thrombin. hirudin coupled-thrombin or 3.4-DCI-treated thrombin.
In contrast to thrombin-enhanced TF mRNA. either hirudin-
thrombin or 3.4-DCI--thrombin used at the same concentration as
actis e thrombin showed a sianificantly decreased TF mRNA
expression in SW480 cells (0.4- and 0.5-fold respectixelsv.
Effect of PKC inhibitors on thrombin-enhanced TF
mRNA levels
PKC inhibitors were used in conjunction with thrombin to identify
the signal transduction pathways involved in the regulation of TF
gene expression. SW-480 cells treated with increasing concentra-
tions of either staurosporine (0.25-1 -NM) or calphostin C (1.25-
5 gm) showed a dose-dependent decrease in the production of TF
mRNA. Table 1 showed the quantitative results of the inhibitors'
effects of staurosporine and calphostin C on thrombin-enhanced
TF mRNA expression in SW-480 cells.
Effect of staurosporine on TF mRNA stability
After incubation with thrombin for 2 h. transcription was arrested
by actinomycin D and further incubation was performed with or
x-ithout the addition ofstaurosporine (1 JIm). The disappearance of
TF mRNA with time was analysed by RT-PCR with scanning
densitometr'. As shown in Figure 6. the yield of mature 2.8-kb TF
mRNA fell in a similar way in the presence or absence of
staurosporine. A 50%c decrease in TF mRNA was detected at about
1.5 h in both conditions. suggesting that the addition of stau-
rosporine after the arrest oftranscription did not modify the disap-
pearance rate ofTF mRNA.
DISCUSSION
Experimental evidence suggests that blood coagulation is acti-
vated at the site of tumour cell lodgement and plays a role in the
pathology of metastatic tumour growth. Procoagulant activitx
produced by tumour cells has been implicated in this process
(Amirkhosravi et al. 1995). The common occurrence ofactisvating
blood coaaulation in most cancer patients leads to the aeneration
of thrombin. thus. it seems reasonable to explore whether
thrombin has any direct influence in enhancing the process of
tumour cell metastasis. Thrombin has been reported to favour
metastatic spread of cancer by promoting cell migration.
enhancing tumour-cell adhesion. stimulating secretion ofautocrine
British Joumal ofCancer (1998) 78(9), 1121-1127
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growth factor or inducing neovascularization because ofits role in
TCIPA andfibrin formation (Nierodzik etal, 1991; Zacharski etal,
1990; Chiang etal, 1995). Ourpresent study showed that thrmbin
enhanced PCA of SW480 human colon adenocarcinoma cells by
enhancing their TF expression, which may occur in vivo, potenti-
ating the haematogenous metastatic ability oftumour cells.
Thrombin has previously been shown to elicit avariety offunc-
tional responses in human endothelial cell cultures, including
induction ofTF mRNA and protein synthesis in a time- and dose-
dependent manner (Galdal et al, 1985; Bartha et al, 1993). A
similar effect was also reported in cultured vascular smooth
muscle cells (Taubman et al, 1993). The data presented here show
that the PCA of SW-480 human colon adenocarcinoma cells was
up-regulated by thrombin as well as by PMA. The thrombin-
enhanced PCA was inhibited by phospholipase C and was not
expressed when tested in factor VII-deficient plasma, thus
confirning that the up-regulated PCA was due to the enhanced TF
activity of SW-480 cells. This is consistent with the previous
observation that close association with certain membrane phos-
pholipids is essential for the functional activity ofTF, as phospho-
lipase C tratment destroyed procoagulant activity of TF in
monocytes and renal glomeruli (Otnaess et al. 1972; Komberg
et al, 1994; Tipping et al, 1998). The time- and dose-dependent
manner of thrombin in enhancing PCA suggests a thrombin
receptor-mediated mode of action, but the identification of the
receptors and their role in mediating thrombin-enhanced TF
activity are not known. However, we found that the active site of
seine residue in thrombin molecule was a prerequisite for its full
expression on TF activity, as ptreatment of thrombin with
hirudin or 3,4-DCI resulted in a lower potency than the native
thrombin. In addition, recent data suggested that the effect of
thrombin on inducing TF mRNA levels in endothelial cells might
be at least partly mediated through 'tethered ligand' thrombin
receptor (Deguchi et al, 1997; Bartha et al, 1993), as recently
reported byWojtujiewicz et al (1995) with human colon adenocar-
cinoma (colon A) and by Fisher et al (1995) with M24met
melanoma cells.
Thrombin- and PMA-enhanced TF activity showed a bell-
shaped dose-response curve with optimal concentration at
1 U mn-' and 0.1 tM respectively. At higher concentrations, both
agonists enhanced less TF activity. In addition, the same profile
was found for TF antigen (data not shown). The mechanism by
which high concentrations of both agonists induced a decrease in
TF activity and antigen is unclear, although PMA has been
reported to shed TF from the cell membrane (Brozna and Carson
1988). Several observations have suggested that PKC is involved
in mediating the cellular effects ofthrombin (Herrick-Davis et al,
1997; Gomez et al, 1988). To determine whether the effects
involved PKC or other protein kinases, the inhibitors tested were
staurosporine and calphostin C. Staurosporine interferes with the
ATP-binding sites ofPKC, whereas calphostin C appears to inter-
fere with the phospholipid-binding regulatory site and is much
more specific for PKC when used appropriately (Bruns et al,
1991). Both inhibitors blocked the thrombin-enhanced TF activity
in a concentration-dependent manner and negatively affected the
TF mRNA content, indicating that exposure of SW-480 to
thrombin activates PKC, and that this activation is involved in the
induction of TF gene expression, thereby leading to the synthesis
of TF by SW-480 cells. Furthermore, treatment of the cells with
cycloheximide and actinomycin D completely inhibited the
TF activity enhanced by both agents, suggesting that de novo
synthesis of protein and mRNA is required. The mechanism
whereby PKC activation leads to de novo synthesis ofTF protein
and mRNA remains to be elucidated. PKC represents a family of
serinethreonine protein kinases that provide regulatory functions
in intracellular signal transduction and are implicated in tumour
growth, promotion and differentiation as well as oncogene activa-
tion and carcinogenesis (Liu et al, 1992).
To date only initial investigations have been made into the
modulation of constitutive TF expression in other systems. In
COS-7 cells, expressing high levels of TF in culture, a novel
serum response element has been found in the TFpromoter region
(Mackman et al, 1990). In general, the TF gene has been classified
as an immediate early gene responsive to serum, purified growth
factors or certain hormones, which has suggested that TF may
participate in biological processes other than haemostasis,
including cell proliferation, inflammatory responses, wound
healing and the effector limb ofthe immune system. Whereas the
PKC inhibitor-induced decrease in T mRNA supports the possi-
bility of a decrease in TF wanscription, the method of RNA
analysis used could not distinguish between an effect on the
wanscription rate and/or an effect on TF mRNA stability. As TF
mRNA stability was unaffected by the addition of staurosporine
after arrest of transcription by actinomycin D, a post-transcrip-
tional mechanism induced by this inhibitor is unlikely to be
involved in the decrease in TF mRNA levels. These results are in
accordance with those obtained with other genes, stating that
stability is unaffected by treatment with H7, a specific PKC
inhibitor. In contrast, the decay rate of tumour necrosis factor a
mRNA is greatly enhanced by PKC inhibitor, which significantly
increases the rate ofpoly(A) removal from tumour necrosis factor
a mRNA, thus facilitating its degradation (Lieberman et al, 1992).
In conclusion, our results suggest that thrombin-enhanced TF
expression in SW-480 human colon adenocarcinoma cells
involves PKC activation. Staurosporine-suppressed TF mRNA
was not associated with an apparent alteration in its stability,
suggesting that the effect is mainly attributable to a decrease in
transcription. As the enhancement of TF expression in tumour
cells by thrombin may contribute to the haematogenous phase of
metastasis, furter investigation of the intracellular signalling
pathways involved in thrombin-enhanced TF synthesis will open
up the possibility ofmodulating this response.
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